Treatment of allergic rhinitis with a new long-acting H1 receptor antagonist: astemizole.
D000328:Adult; D001066:Appetite / Q000187:drug effects; D016589:Astemizole; D001562:Benzimidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D002744:Chlorpheniramine / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D012894:Sleep Stages / Q000187:drug effects; D014987:Xerostomia / Q000139:chemically induced
D001562:Benzimidazoles; D006634:Histamine H1 Antagonists; C018904:dexchlorpheniramine; D002744:Chlorpheniramine; D016589:Astemizole